[First experience using an aromatase inhibitor in combination with growth hormone to improve growth prognosis in a 14-year-old boy with growth hormone deficiency after treatment of craniopharyngioma. A case-report]. [PDF]
Probl Endokrinol (Mosk)Mazerkina NA +4 more
europepmc +1 more source
[Metastatic lesions of the adrenal glands. The experience of Endocrinology Research Center.] [PDF]
Probl Endokrinol (Mosk), 2023 Pachuashvili NV +7 more
europepmc +1 more source
[Modern strategies for the treatment of childhood obesity]. [PDF]
Probl Endokrinol (Mosk), 2022 Okorokov PL +2 more
europepmc +1 more source
[Efficacy of standard methods in the treatment of prolactin-secreting pituitary carcinoma]. [PDF]
Probl Endokrinol (Mosk)Astafyeva LI +4 more
europepmc +1 more source
[Metastatic risk factors in pheochromocytoma/paraganglioma]. [PDF]
Probl Endokrinol (Mosk), 2023 Rebrova DV +15 more
europepmc +1 more source
[Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG]. [PDF]
Probl Endokrinol (Mosk)Shlyakhto EV +22 more
europepmc +1 more source
Forecast for the zone of viticulture in European Russia under climate change. [PDF]
Vavilovskii Zhurnal Genet Selektsii, 2022 Novikova LY, Ozerski PV.
europepmc +1 more source
[Replicative and biochemical ageing mechanisms among females with Turner syndromes]. [PDF]
Probl Endokrinol (Mosk)Mikheev RK +5 more
europepmc +1 more source
[Endocrine disorders after combined chemoradiotherapy in Hodgkin Lymphoma survivors]. [PDF]
Probl Endokrinol (Mosk), 2023 Voytko MS +4 more
europepmc +1 more source
[Efficacy of treatment with glucagon-like peptide receptor agonists-1 in Asian patients with type 2 diabetes mellitus]. [PDF]
Probl Endokrinol (Mosk), 2023 Khamnueva LY, Andreeva LS.
europepmc +1 more source